title: Comment: Plateaus and reversals in ALS disease course or limitations of trial design?
authors.affiliation: From the Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, the Netherlands.
authors.forename: Ruben P A
authors.initials: RP
authors.lastname: van Eijk
authors.affiliation: From the Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, the Netherlands.
authors.forename: Leonard H
authors.initials: LH
authors.lastname: van den Berg
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000175:diagnosis* / Q000453:epidemiology*; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data*; D006801:Humans; D012042:Registries; D012075:Remission, Spontaneous